Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-03-05
2019-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers
NCT06910579
The Effect of Photobiomodulation on Pressure Ulcers
NCT07307885
Non-Thermal Plasma vs. Low-Level Laser Therapy for Recurrent Oral Ulcers
NCT07322666
Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.
NCT07135609
Extracorporeal Shockwave Therapy for Diabetic Foot Ulcers
NCT05380544
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Photodynamic Therapy (PDT) Group
Patients in the PDT group were treated in a single session on the day of admission to the clinic. Indocyanine green (Perio green, Elexxion AG, Radolfzell, Germany) prepared and applied according to manufacturer's instructions steps (mixing, application, soaking phase, rinsing, activation) in a concentration with 0.1mg/mL was administered via fine-needle syringe as the photosensitizer. Following the completion of topical application of the photosensitizer to the lesion surface, a (GaAlAs) diode laser device (Cheese Diode Laser, Wuhan Gigaa Optronics Technology Co. Ltd, China) in continuous mode (810 nm, 300 mW, 10,000 kHz, 1.26 cm2 spot area), with a 400 μm polymethylmethacrylate optical fiber tip, scanning from the periphery to the center of the lesion with an energy density of approximately 10 J/cm2 for 40 s and applied non-contact at a distance of 1 mm.
Photodynamic therapy (indocyanine green+laser)
Photodynamic therapy with indocyanine green
Control Group
The lesions of the patients in the control group were not treated but only followed up. Recommendations were made to reduce their pain (avoidance of hot, spicy and acidic foods, attention to oral hygiene, etc.)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Photodynamic therapy (indocyanine green+laser)
Photodynamic therapy with indocyanine green
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With a history of canker sores not exceeding 2 days,
* Not taking any antibiotics or anti-inflammatory drugs.
Exclusion Criteria
* Pregnancy,
* Smoking habbit,
* Poor oral hygiene,
* Patients under 18 years of age
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yuzuncu Yıl University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cennet Neslihan Eroglu
Assoc Prof Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cennet N Eroglu, DDS,PhD
Role: PRINCIPAL_INVESTIGATOR
Yuzuncu Yıl University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yuzuncu Yil University
Van, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06/16022018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.